首页    期刊浏览 2025年02月21日 星期五
登录注册

文章基本信息

  • 标题:Percepo de farmacêuticos sobre o descumprimento do protocolo e das diretrizes terapêuticas para dislipidemia e os desafios para a gesto do Sistema único de Saúde
  • 本地全文:下载
  • 作者:Karina Uggere de Andrade Campelo ; Camila Ferreira Mariani ; Juliana André Vindor
  • 期刊名称:Research, Society and Development
  • 电子版ISSN:2525-3409
  • 出版年度:2022
  • 卷号:11
  • 期号:8
  • 页码:1-14
  • DOI:10.33448/rsd-v11i8.31217
  • 语种:English
  • 出版社:Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
  • 摘要:The study aimed to assess compliance with clinical protocol and therapeutic guidelines (CPTG) for dyslipidemia for the prevention of cardiovascular events and pancreatitis. This was a retrospective observational study of medication release processes for the treatment of dyslipidemia in medication dispensing pharmacies of the specialized component of pharmaceutical service and analytical-descriptive guidance of a qualitative nature with pharmacists and system managers. The processes of patients undergoing treatment with statins and fibrates and with data from at least one year of medication use and also pharmacists working in the dispensing of medications and managers were included in the research. A total of 146 processes were analyzed and 36 pharmacists and 6 managers participated in the qualitative approach. Ninety cases (61.6%) presented the described inclusion criteria. Only in seven (19.4%) cases the initial triglyceride values were above 500mg/dL and in 72.3% the values were lower than recommended. No report of exclusion criteria was identified for users of the analyzed processes, however, in relation to hyperthyroidism, 2.1% processes had TSH levels above 10mcUI/mL and 7.5% had no data on the dosage of this hormone. Initial measurements of CPK and liver transaminases were not present in 10 (6.8%) and 5 (3.4%) cases, respectively. In conclusion, it was possible to understand that there is no effective compliance with what is standardized in the PCDT for dyslipidemia and that the continuing education of professionals and management commitment to this continuous improvement must be priorities to ensure the safety and effectiveness of the treatment.
  • 关键词:Pharmaceutical service;Cardiovascular diseases;Pharmacological treatment;Medicines from the specialized component of pharmaceutical service;Health promotion.
国家哲学社会科学文献中心版权所有